Peter J Arnold1, Mary E Soyster2, Ramzy T Burns2, Matthew J Mellon2. 1. Department of Urology, Indiana University School of Medicine, 535 Barnhill Drive, Suite 150, Indianapolis, IN, USA. pearnold@iu.edu. 2. Department of Urology, Indiana University School of Medicine, 535 Barnhill Drive, Suite 150, Indianapolis, IN, USA.
Abstract
PURPOSE: To provide our single-center experience with an approach to refractory stress urinary incontinence (SUI) with permanent urethral ligation (PUL) and suprapubic tube (SPT) placement, in hopes of contributing to the limited body of research surrounding this surgical treatment option for patients with end-stage urethra (ESU). METHODS: All patients undergoing PUL with SPT placement from 01/01/2018 to 04/30/2022 were identified from an institutional database. Institutional Review Board exempt status was granted for the conduct of this study. Patients were seen postoperatively at 1 month and 1 year. If there were any concerns of incontinence, an antegrade urethrogram via the SPT was performed. Descriptive statistics were used to evaluate patients. RESULTS: Seven patients underwent PUL with SPT in our timeframe and were included in the study. All patients previously had an AUS placed, and two patients had a urethral sling previously placed. The median follow-up time was 21 months, ranging between 2 and 48 months. Complications included bladder spasms (43%) and continued leakage per urethra (14%). Of the 7 patients, 6 have reported continence through their urethra at their most recent follow-up. CONCLUSION: This initial data suggest that PUL with SPT placement may be a viable surgical approach to treating refractory SUI, especially for patients with ESU who wish to avoid the morbidity associated with more formal supravesical diversion. Further study of this technique and longer follow-up is required to determine its long-term efficacy and tolerability for patients.
PURPOSE: To provide our single-center experience with an approach to refractory stress urinary incontinence (SUI) with permanent urethral ligation (PUL) and suprapubic tube (SPT) placement, in hopes of contributing to the limited body of research surrounding this surgical treatment option for patients with end-stage urethra (ESU). METHODS: All patients undergoing PUL with SPT placement from 01/01/2018 to 04/30/2022 were identified from an institutional database. Institutional Review Board exempt status was granted for the conduct of this study. Patients were seen postoperatively at 1 month and 1 year. If there were any concerns of incontinence, an antegrade urethrogram via the SPT was performed. Descriptive statistics were used to evaluate patients. RESULTS: Seven patients underwent PUL with SPT in our timeframe and were included in the study. All patients previously had an AUS placed, and two patients had a urethral sling previously placed. The median follow-up time was 21 months, ranging between 2 and 48 months. Complications included bladder spasms (43%) and continued leakage per urethra (14%). Of the 7 patients, 6 have reported continence through their urethra at their most recent follow-up. CONCLUSION: This initial data suggest that PUL with SPT placement may be a viable surgical approach to treating refractory SUI, especially for patients with ESU who wish to avoid the morbidity associated with more formal supravesical diversion. Further study of this technique and longer follow-up is required to determine its long-term efficacy and tolerability for patients.
Authors: Robert K Nam; Sender Herschorn; D Andrew Loblaw; Ying Liu; Laurence H Klotz; Lesley K Carr; Ronald T Kodama; Aleksandra Stanimirovic; Vasundara Venkateswaran; Refik Saskin; Calvin H L Law; David R Urbach; Steven A Narod Journal: J Urol Date: 2012-06-15 Impact factor: 7.450
Authors: M Verhoef; M Lurvink; H A Barf; M W M Post; F W A van Asbeck; R H J M Gooskens; A J H Prevo Journal: Spinal Cord Date: 2005-06 Impact factor: 2.772
Authors: Min Chul Cho; Ji Hyun Park; Min Su Jeong; Jun-Seok Yi; Ja Hyeon Ku; Seung-June Oh; Soo Woong Kim; Jae-Seung Paick Journal: Neurourol Urodyn Date: 2011-04-28 Impact factor: 2.696
Authors: Roger K Khouri; Nicolas M Ortiz; Adam S Baumgarten; Ellen E Ward; Maia E VanDyke; Steven J Hudak; Allen F Morey Journal: Urology Date: 2020-04-11 Impact factor: 2.649